Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 23, 2020

SELL
$13.31 - $20.51 $365,439 - $563,122
-27,456 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$12.98 - $30.25 $232,173 - $541,081
17,887 Added 186.93%
27,456 $426,000
Q4 2019

Jan 21, 2020

SELL
$18.89 - $31.89 $24,557 - $41,457
-1,300 Reduced 11.96%
9,569 $286,000
Q3 2019

Oct 29, 2019

BUY
$20.88 - $25.66 $22,968 - $28,226
1,100 Added 11.26%
10,869 $237,000
Q2 2019

Jul 29, 2019

SELL
$20.52 - $26.45 $337,964 - $435,631
-16,470 Reduced 62.77%
9,769 $246,000
Q1 2019

Apr 30, 2019

SELL
$20.23 - $26.29 $34,391 - $44,693
-1,700 Reduced 6.08%
26,239 $648,000
Q4 2018

Feb 01, 2019

SELL
$17.64 - $28.32 $30,711 - $49,305
-1,741 Reduced 5.87%
27,939 $516,000
Q3 2018

Nov 05, 2018

BUY
$20.64 - $25.67 $612,595 - $761,885
29,680 New
29,680 $762,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.63B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.